Colinz Laboratories is in the business of manufacturing and trading in pharmaceutical formulationsBusiness Overview: http://www.colinz.com/about.html CLL is a manufacturer and exporter of pharmaceutical formulations for allopathic, ayurvedic, nutraceticals in dosage forms of tablets, capsules, ointments, creams, granules, liquid, orals, injectables, syrups, suppsitories, etc. It also has certain specialized products…
Colinz Laboratories Limited has announced its unaudited financial results for the quarter ended June 30. The company reported revenue from operations of Rs. 1.64 Cr. Net profit after tax for the period stood at Rs. 0.14 Cr. Basic earnings per share (EPS) for the quarter was Rs. 0.54. These results,...
Colinz Laboratories has announced a certificate from its Registrar and Share Transfer Agent, Bigshare Services Pvt. Ltd., confirming that securities received for dematerialization in the quarter were verified, mutilated, and cancelled properly. The related securities have been listed on the stock exchange where earlier securities are traded. The name of...
Colinz Laboratories has announced a board meeting to appoint Mr. Swapnil Fayesh Madiyar as an Additional Director in the category of Non-Promoter, Non-Executive. This appointment, recommended by the Remuneration Committee, brings extensive experience across business, fintech, marketing, HR, technology, and business development. Mr. Madiyar is not related to any existing...
Colinz Laboratories has announced a board meeting on 16th May, 2025, to approve the financial results for the quarter and half-year. The company reported revenue from operations of Rs. 730.46 lakh for the quarter ended March 31, 2025. Net profit before tax stood at Rs. 18.96 lakh, while profit after...
